Primary MHC-Class II+ cells are necessary to promote resting Vδ2 cell expansion in response to (E)-4-hydroxy-3-methyl-but-2-enyl- pyrophosphate and isopentenyl pyrophosphate

Journal of Immunology

Volumn 189, Issue 11, 2012, Pages 5212-5222

  Soriano Sarabia, Natalia ^a   Sandvold, Hakon ^a   Jomaa, Hassan ^a   Kubin, Thomas ^b   Bein, Gregor ^a   Hackstein, Holger ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXY 3 METHYL BUT 2 ENYL PYROPHOSPHATE; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; ISOPENTENYL DIPHOSPHATE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; PYROPHOSPHORIC ACID DERIVATIVE; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL SEPARATION; CELL SPECIFICITY; CELL STIMULATION; CONTROLLED STUDY; DENDRITIC CELL; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MONOCYTE; PRIORITY JOURNAL; PURIFICATION; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; T LYMPHOCYTE; T LYMPHOCYTE RECEPTOR ALPHA BETA T LYMPHOCYTE; V GAMMA9 DELTA2 T LYMPHOCYTE;

ANTIBODIES; ANTIGENS, CD; B-LYMPHOCYTES; CELL PROLIFERATION; CELL SEPARATION; DENDRITIC CELLS; DIPHOSPHATES; GENE EXPRESSION; HEMITERPENES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOLOGIC FACTORS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MONOCYTES; ORGANOPHOSPHORUS COMPOUNDS; PRIMARY CELL CULTURE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES;

EID: 84869834167     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200093     Document Type: Article

References (45)

1. Tanaka, Y., S. Sano, E. Nieves, G. De Libero, D. Rosa, R. L. Modlin, M. B. Brenner, B. R. Bloom, and C. T. Morita. 1994. Nonpeptide ligands for human gamma delta T cells. Proc. Natl. Acad. Sci. USA 91: 8175-8179. (Pubitemid 24253909)
2. Tanaka, Y., C. T. Morita, Y. Tanaka, E. Nieves, M. B. Brenner, and B. R. Bloom. 1995. Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature 375: 155-158.
3. Kabelitz, D. 2011. γδ T-cells: cross-talk between innate and adaptive immunity. Cell. Mol. Life Sci. 68: 2331-2333.
4. Hintz, M., A. Reichenberg, B. Altincicek, U. Bahr, R. M. Gschwind, A. K. Kollas, E. Beck, J. Wiesner, M. Eberl, and H. Jomaa. 2001. Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human gammadelta T cells in Escherichia coli. FEBS Lett. 509: 317-322. (Pubitemid 34015963)
5. Jomaa, H., J. Wiesner, S. Sanderbrand, B. Altincicek, C. Weidemeyer, M. Hintz, I. Türbachova, M. Eberl, J. Zeidler, H. K. Lichtenthaler, et al. 1999. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science 285: 1573-1576. (Pubitemid 29420582)
6. Poupot, M., and J.-J. Fournié. 2004. Non-peptide antigens activating human Vgamma9/Vdelta2 T lymphocytes. Immunol. Lett. 95: 129-138. (Pubitemid 39242672)
7. Altincicek, B., J. Moll, N. Campos, G. Foerster, E. Beck, J. F. Hoeffler, C. Grosdemange-Billiard, M. Rodríguez-Concepción, M. Rohmer, A. Boronat, et al. 2001. Cutting edge: human gamma delta T cells are activated by intermediates of the 2-C-methyl-D-erythritol 4-phosphate pathway of isoprenoid biosynthesis. J. Immunol. 166: 3655-3658. (Pubitemid 32224885)
8. Kunzmann, V., E. Bauer, J. Feurle, F. Weissinger, H. P. Tony, and M. Wilhelm. 2000. Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 96: 384-392. (Pubitemid 30463353)
9. Wilhelm, M., V. Kunzmann, S. Eckstein, P. Reimer, F. Weissinger, T. Ruediger, and H.-P. Tony. 2003. Gammadelta T cells for immune therapy of patients with lymphoid malignancies. Blood 102: 200-206. (Pubitemid 36759655)
10. Morita, C. T., E. M. Beckman, J. F. Bukowski, Y. Tanaka, H. Band, B. R. Bloom, D. E. Golan, and M. B. Brenner. 1995. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells. Immunity 3: 495-507.
11. Sarikonda, G., H. Wang, K.-J. Puan, X. H. Liu, H. K. Lee, Y. Song, M. D. Distefano, E. Oldfield, G. D. Prestwich, and C. T. Morita. 2008. Photoaffinity antigens for human gammadelta T cells. J. Immunol. 181: 7738-7750.
12. Wei, H., D. Huang, X. Lai, M. Chen, W. Zhong, R. Wang, and Z. W. Chen. 2008. Definition of APC presentation of phosphoantigen (E)-4-hydroxy-3-methyl- but-2-enyl pyrophosphate to Vgamma2Vdelta 2 TCR. J. Immunol. 181: 4798-4806.
13. Kato, Y., Y. Tanaka, F. Miyagawa, S. Yamashita, and N. Minato. 2001. Targeting of tumor cells for human gammadelta T cells by nonpeptide antigens. J. Immunol. 167: 5092-5098. (Pubitemid 33009743)
14. Kato, Y., Y. Tanaka, H. Tanaka, S. Yamashita, and N. Minato. 2003. Requirement of species-specific interactions for the activation of human gamma delta T cells by pamidronate. J. Immunol. 170: 3608-3613. (Pubitemid 36359229)
15. Miyagawa, F., Y. Tanaka, S. Yamashita, and N. Minato. 2001. Essential requirement of antigen presentation by monocyte lineage cells for the activation of primary human gamma delta T cells by aminobisphosphonate antigen. J. Immunol. 166: 5508-5514. (Pubitemid 32374172)
16. Devilder, M.-C., S. Maillet, I. Bouyge-Moreau, E. Donnadieu, M. Bonneville, and E. Scotet. 2006. Potentiation of antigen-stimulated V gamma 9V delta 2 T cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturation. J. Immunol. 176: 1386-1393. (Pubitemid 43134280)
17. Eberl, M., M. Hintz, Z. Jamba, E. Beck, H. Jomaa, and G. Christiansen. 2004. Mycoplasma penetrans is capable of activating V gamma 9/V delta 2 T cells while other human pathogenic mycoplasmas fail to do so. Infect. Immun. 72: 4881-4883. (Pubitemid 38989351)
18. Ali, Z., L. Shao, L. Halliday, A. Reichenberg, M. Hintz, H. Jomaa, and Z. W. Chen. 2007. Prolonged (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate-driven antimicrobial and cytotoxic responses of pulmonary and systemic Vgamma2Vdelta2 T cells in macaques. J. Immunol. 179: 8287-8296.
19. Hecht, S., S. Amslinger, J. Jauch, K. Kis, V. Trentinaglia, P. Adam, W. Eisenreich, A. Bacher, and F. Rohdich. 2002. Studies on the non-mevalonate isoprenoid biosynthetic pathway: simple methods for preparation of isotope-labeled (E)-1-hydroxy-2-methylbut-2-enyl 4-diphosphate. Tetrahedron Lett. 43: 8929-8933. (Pubitemid 35335679)
20. Kunzmann, V., B. Kimmel, T. Herrmann, H. Einsele, and M. Wilhelm. 2009. Inhibition of phosphoantigen-mediated gammadelta T-cell proliferation by CD4+ CD25+ FoxP3+ regulatory T cells. Immunology 126: 256-267.
21. Mahan, C. S., J. J. Thomas, W. H. Boom, and R. E. Rojas. 2009. CD4+ CD25 (high) Foxp3+ regulatory T cells downregulate human Vdelta2+ T-lymphocyte function triggered by anti-CD3 or phosphoantigen. Immunology 127: 398-407.
22. Kitamura, H., K. Iwakabe, T. Yahata, S. Nishimura, A. Ohta, Y. Ohmi, M. Sato, K. Takeda, K. Okumura, L. Van Kaer, et al. 1999. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 189: 1121-1128.
23. Fujii, S.-i., K. Shimizu, M. Kronenberg, and R. M. Steinman. 2002. Prolonged IFN-gamma-producing NKT response induced with alpha- galactosylceramide-loaded DCs. Nat. Immunol. 3: 867-874.
24. Ismaili, J., V. Olislagers, R. Poupot, J.-J. Fournié, and M. Goldman. 2002. Human gamma delta T cells induce dendritic cell maturation. Clin. Immunol. 103: 296-302. (Pubitemid 34666753)
25. Conti, L., R. Casetti, M. Cardone, B. Varano, A. Martino, F. Belardelli, F. Poccia, and S. Gessani. 2005. Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gammadelta T cells: role of CD86 and inflammatory cytokines. J. Immunol. 174: 252-260. (Pubitemid 40007411)
26. Caccamo, N., G. Sireci, S. Meraviglia, F. Dieli, J. Ivanyi, and A. Salerno. 2006. gammadelta T cells condition dendritic cells in vivo for priming pulmonary CD8 T cell responses against Mycobacterium tuberculosis. Eur. J. Immunol. 36: 2681-2690. (Pubitemid 44608452)
27. Gruenbacher, G., H. Gander, A. Rahm, W. Nussbaumer, N. Romani, and M. Thurnher. 2009. CD56+ human blood dendritic cells effectively promote TH1-type gammadelta T-cell responses. Blood 114: 4422-4431.
28. Devilder, M.-C., S. Allain, C. Dousset, M. Bonneville, and E. Scotet. 2009. Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells. J. Immunol. 183: 3625-3633.
29. Nussbaumer, O., G. Gruenbacher, H. Gander, and M. Thurnher. 2011. DC-like cell-dependent activation of human natural killer cells by the bisphosphonate zoledronic acid is regulated by γδ T lymphocytes. Blood 118: 2743-2751.
30. Meraviglia, S., N. Caccamo, A. Salerno, G. Sireci, and F. Dieli. 2010. Partial and ineffective activation of V gamma 9V delta 2 T cells by Mycobacterium tuberculosis-infected dendritic cells. J. Immunol. 185: 1770-1776.
31. Bonneville, M., R. L. O'Brien, and W. K. Born. 2010. Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat. Rev. Immunol. 10: 467-478.
32. Kato, Y., Y. Tanaka, M. Hayashi, K. Okawa, and N. Minato. 2006. Involvement of CD166 in the activation of human gamma delta T cells by tumor cells sensitized with nonpeptide antigens. J. Immunol. 177: 877-884. (Pubitemid 44036588)
33. Vantourout, P., J. Mookerjee-Basu, C. Rolland, F. Pont, H. Martin, C. Davrinche, L. O. Martinez, B. Perret, X. Collet, C. Périgaud, et al. 2009. Specific requirements for Vgamma9Vdelta2 T cell stimulation by a natural adenylated phosphoantigen. J. Immunol. 183: 3848-3857.
34. Ali, Z., L. Yan, N. Plagman, A. Reichenberg, M. Hintz, H. Jomaa, F. Villinger, and Z. W. Chen. 2009. Gammadelta T cell immune manipulation during chronic phase of simian-human immunodeficiency virus infection [corrected] confers immunological benefits. J. Immunol. 183: 5407-5417.
35. Hirano, T. 1992. The biology of interleukin-6. Chem. Immunol. 51: 153-180.
36. Robinson, L. J., M. C. D'Ombrain, D. I. Stanisic, J. Taraika, N. Bernard, J. S. Richards, J. G. Beeson, L. Tavul, P. Michon, I. Mueller, and L. Schofield. 2009. Cellular tumor necrosis factor, gamma interferon, and interleukin-6 responses as correlates of immunity and risk of clinical Plasmodium falciparum malaria in children from Papua New Guinea. Infect. Immun. 77: 3033-3043.
37. Lin, Y., S. Ritchea, A. Logar, S. Slight, M. Messmer, J. Rangel-Moreno, L. Guglani, J. F. Alcorn, H. Strawbridge, S. M. Park, et al. 2009. Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity 31: 799-810.
38. Curtis, M. M., and S. S. Way. 2009. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 126: 177-185.
39. Martin, B., K. Hirota, D. J. Cua, B. Stockinger, and M. Veldhoen. 2009. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 31: 321-330.
40. Sutton, C. E., S. J. Lalor, C. M. Sweeney, C. F. Brereton, E. C. Lavelle, and K. H. G. Mills. 2009. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31: 331-341.
41. Rochman, Y., R. Spolski, and W. J. Leonard. 2009. New insights into the regulation of T cells by gamma(c) family cytokines. Nat. Rev. Immunol. 9: 480-490.
42. Bonneville, M., and E. Scotet. 2006. Human Vgamma9Vdelta2 T cells: promising new leads for immunotherapy of infections and tumors. Curr. Opin. Immunol. 18: 539-546. (Pubitemid 44311448)
43. Hayday, A. C. 2009. Gammadelta T cells and the lymphoid stress-surveillance response. Immunity 31: 184-196.
44. Laggner, U., J. S. Lopez, G. Perera, V. S. Warbey, A. Sita-Lumsden, M. J. O'Doherty, A. Hayday, M. Harries, and F. O. Nestle. 2009. Regression of melanoma metastases following treatment with the n-bisphosphonate zoledronate and localised radiotherapy. Clin. Immunol. 131: 367-373.
45. Huang, D., C. Y. Chen, Z. Ali, L. Shao, L. Shen, H. A. Lockman, R. E. Barnewall, C. Sabourin, J. Eestep, A. Reichenberg, et al. 2009. Antigen-specific Vgamma2Vdelta2 T effector cells confer homeostatic protection against pneumonic plaque lesions. Proc. Natl. Acad. Sci. USA 106: 7553-7558.